Drug addicts entitled to disability insurance, says court
Switzerland’s consumption of morphine and equivalent drugs has risen from practically zero in the 1980s to 400mg per inhabitant in 2015, placing the country 7th in the world ranking.
Copyright 2018 The Associated Press. All Rights Reserved.
Switzerland’s highest court has decided to extend in principle the right to disability insurance benefits to people with drug addiction.
With the decision by the Federal Court, people with drug dependencies who have been evaluated and diagnosed by a medical specialist can access disability insurance benefits. This in effect treats drug addiction in the same vein as a mental illness.
According to the court, the ruling, which was announced on Monday, was based on a thorough review of existing medical knowledge.
This reverses previous case law that viewed drug addiction as the individual’s responsibility and treatable through drug withdrawal. Up to now, individuals with drug addiction could only receive disability benefits if the addiction caused an illness or accident or if the dependency was the result of an illness.
As is the case with many other mental disorders, determining whether the person can receive disability benefits is based on a structured evaluation of whether the person can, despite the condition diagnosed medically, pursue suitable productive activity on a full-time or part-time basis.
In order to receive benefits, the person must pursue mitigation measures such as reasonable medical treatment. If the person refuses, benefits can be revoked.
The case that served as the basis for the decision was an appeal received by the court by a man dependent on benzodiazepines and opioids who had unsuccessfully applied for disability insurance. The judges concluded that the psychiatric expertise carried out on the person concerned, resulted in incapacity for work due to drug addiction.
More
More
Opioid painkiller prescriptions surge in Switzerland
This content was published on
Prescription for powerful opioid medication have increased twenty-fold in the last thirty years, a recent study has found.
Diversity and equality ‘under threat’: ex-Swiss minister
This content was published on
Dismantling diversity programmes is a backwards step for equality, warns former Swiss government minister Simonetta Sommaruga.
Swiss regulator fines US bank Citi over fat-finger crash
This content was published on
Citigroup fined CHF500,000 by Swiss stock exchange regulator after a fat-finger trade caused a 2022 flash crash in European stocks.
Swiss steel industry offered four-year state subsidies
This content was published on
Strategically important steel companies in Switzerland are eligible for state aid from the start of this year until the end of 2028.
Swiss companies failing to observe equal pay obligations
This content was published on
Many Swiss companies are failing to carry out their legal obligation to monitor equal pay, says the Federal Office of Justice.
This content was published on
The Swiss Federal Supreme Court has overturned the conviction of a commodities trader who had been given a suspended sentence and fined CHF72 million.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Painkillers linked to heart attack risks
This content was published on
The report by researchers from Bern University, published in the British Medical Journal, looked at 31 clinical trials on more than 116,000 patients to examine the effects of painkillers on people’s health. The team studied data from existing large-scale studies comparing use of non-steroidal anti-inflammatory drugs (NSAIDs) as well as new-generation anti-inflammatory medicines (COX-2 inhibitors)…
This content was published on
In the U.S., abuse of opioids causes more death than firearms. But also in Switzerland, consumption is on the rise. A reason to worry?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.